Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
79.52
-3.66 (-4.40%)
Nov 17, 2026, 3:00 PM CST

SHA:688266 Revenue

Suzhou Zelgen Biopharmaceuticals had revenue of 331.11M CNY in the quarter ending September 30, 2026, with 52.03% growth. This brings the company's total for the last twelve months to 1.75B, up 136.24% year-over-year. In the year 2025, Suzhou Zelgen Biopharmaceuticals had annual revenue of 810.48M with 52.07% growth. That makes Suzhou Zelgen Biopharmaceuticals the 15,526th largest company in the world by revenue and 2,801st in China.

Revenue (ttm)
1.75B
Revenue Growth
+136.24%
P/S Ratio
12.23
Revenue / Employee
1.66M
Employees
1,055
Market Cap
21.05B

Revenue Chart

Revenue by Geography

  • China 802.64M 99.1%
  • Overseas 7.55M 0.9%
Fiscal year ended Dec 31, 2025 See the full SHA:688266 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025810.48M277.53M52.07%
Dec 31, 2024532.95M146.52M37.91%
Dec 31, 2023386.44M84.13M27.83%
Dec 31, 2022302.31M111.94M58.81%
Dec 31, 2021190.36M162.70M588.19%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.